This News Story is more than 16 years old. Links and contact information may have changed.
Public seminar about cardiometabolic syndrome at 91探花 on September 11
| News
Dr. Bobby V. Khan, of the Emory University School of Medicine, in Atlanta, Georgia, will give a public seminar called Tackling a Growing Problem: New Insights in the Cardiometabolic Syndrome on Thursday, September 11, at 2 p.m. in the Atlantic Veterinary College Lecture Theatre A.
Khan will give the seminar as part of a three-day visit to the 91探花 from September 10 to 13.
People with cardiometabolic syndrome are at increased risk of coronary heart disease, peripheral arterial disease, stroke, and type 2 diabetes, says Khan. Cardiometabolic syndrome is a constellation of risk factors associated with obesity, dyslipidemia, glucose intolerance and hypertension. The incidence of this syndrome is increasing worldwide and is thought to involve 30 per cent of adults in the United States and Canada.
The primary mechanism for the cardiometabolic syndrome appears to be insulin resistance, a disorder in which the body uses insulin in an inefficient manner. In addition to risk factor modification, drug therapy may be indicated. This presentation will discuss current topics that are relevant in managing and treating patients with cardiometabolic syndrome.
Khan is the director of the Coronary Care Unit at Grady Memorial Hospital, and has been on the faculty in the Department of Medicine/Cardiology at Emory University School of Medicine, Atlanta, Georgia, since 1997. He is also director of the Cardiovascular Research Laboratory at Grady Memorial Hospital; his research focuses on preventive cardiology and therapeutics in cardiovascular disease. He has published over 40 peer-reviewed papers and book chapters, and has served as reviewer for several prestigious journals including Circulation, Journal of Clinical Investigation, Atherosclerosis, and JACC (Journal of the American College of Cardiology). He is an abstract reviewer for the scientific sessions of the American College of Cardiology and the American Heart Association.
Refreshments will follow the lecture, which is sponsored by the Atlantic Veterinary College and PEI Health Research Institute at the 91探花. For information, please contact the PEI Health Research Institute at (902) 566-2812.
Khan will give the seminar as part of a three-day visit to the 91探花 from September 10 to 13.
People with cardiometabolic syndrome are at increased risk of coronary heart disease, peripheral arterial disease, stroke, and type 2 diabetes, says Khan. Cardiometabolic syndrome is a constellation of risk factors associated with obesity, dyslipidemia, glucose intolerance and hypertension. The incidence of this syndrome is increasing worldwide and is thought to involve 30 per cent of adults in the United States and Canada.
The primary mechanism for the cardiometabolic syndrome appears to be insulin resistance, a disorder in which the body uses insulin in an inefficient manner. In addition to risk factor modification, drug therapy may be indicated. This presentation will discuss current topics that are relevant in managing and treating patients with cardiometabolic syndrome.
Khan is the director of the Coronary Care Unit at Grady Memorial Hospital, and has been on the faculty in the Department of Medicine/Cardiology at Emory University School of Medicine, Atlanta, Georgia, since 1997. He is also director of the Cardiovascular Research Laboratory at Grady Memorial Hospital; his research focuses on preventive cardiology and therapeutics in cardiovascular disease. He has published over 40 peer-reviewed papers and book chapters, and has served as reviewer for several prestigious journals including Circulation, Journal of Clinical Investigation, Atherosclerosis, and JACC (Journal of the American College of Cardiology). He is an abstract reviewer for the scientific sessions of the American College of Cardiology and the American Heart Association.
Refreshments will follow the lecture, which is sponsored by the Atlantic Veterinary College and PEI Health Research Institute at the 91探花. For information, please contact the PEI Health Research Institute at (902) 566-2812.
Contact
Anna MacDonald
Media Relations and Communications, Integrated Promotions
